Radiotherapy for esophageal carcinoma: dose, response and survival

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• KumagaiKRouvelasITsaiJAMeta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancersBr J Surg2014101432133824493117
   PubMed Web of Science ®Google Scholar
• WheelerJBReedCEEpidemiology of esophageal cancerSurg Clin North Am20129251077108723026270
   PubMed Web of Science ®Google Scholar
• AjaniJAGastroesophageal cancers: progress and problemsJ Natl Compr Canc Netw20086981381418998257
   PubMedGoogle Scholar
• SongYLiLOuYIdentification of genomic alterations in oesophageal squamous cell cancerNature20145097498919524670651
   PubMed Web of Science ®Google Scholar
• CooperJSGuoMDHerskovicAChemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01). Radiation Therapy Oncology GroupJAMA1999281171623162710235156
   PubMed Web of Science ®Google Scholar
• MinskyBDNeubergDKelsenDPFinal report of intergroup trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagusInt J Radiat Oncol Biol Phys199943351752310078631
   PubMed Web of Science ®Google Scholar
• MinskyBDPajakTFGinsbergRJINT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapyJ Clin Oncol20022051167117411870157
   PubMed Web of Science ®Google Scholar
• HiguchiKKoizumiWTanabeSCurrent management of esophageal squamous-cell carcinoma in Japan and other countriesGastrointest Cancer Res20093415316119742141
   PubMedGoogle Scholar
• MengXWangJSunXCetuximab in combination with chemo-radiotherapy in Chinese patients with non-resectable, locally advanced esophageal squamous cell carcinoma: a prospective, multicenter phase II trailRadiother Oncol2013109227528024128808
   PubMed Web of Science ®Google Scholar
• LiMZhangXZhaoFLuoYKongLYuJInvolved-field radiotherapy for esophageal squamous cell carcinoma: theory and practiceRadiat Oncol2016111826846932
   PubMed Web of Science ®Google Scholar
• BedenneLMichelPBouchéOChemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102J Clin Oncol200725101160116817401004
   PubMed Web of Science ®Google Scholar
• RawatSKumarGKakriaASharmaMKChauhanDChemoradiotherapy in the management of locally advanced squamous cell carcinoma esophagus: is surgical resection requiredJ Gastrointest Cancer201344327728423389866
   PubMedGoogle Scholar
• PöttgenCStuschkeMRadiotherapy versus surgery within multimodality protocols for esophageal cancer a meta-analysis of the randomized trialsCancer Treat Rev201238659960422116018
   PubMed Web of Science ®Google Scholar
• KawaguchiYNishiyamaKMiyagiKSuzukiOItoYNakamuraSPatterns of failure associated with involved field radiotherapy in patients with clinical stage I thoracic esophageal cancerJpn J Clin Oncol20114181007101221665908
   PubMed Web of Science ®Google Scholar
• van HagenPHulshofMCvan LanschotJJPreoperative chemoradiotherapy for esophageal or junctional cancerN Engl J Med2012366222074208422646630
   PubMed Web of Science ®Google Scholar
• KatoKNakajimaTEItoYPhase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II–III esophageal carcinomaJpn J Clin Oncol201343660861523585687
   PubMed Web of Science ®Google Scholar
• RohatgiPRSwisherSGCorreaAMFailure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagusCancer200510471349135516130133
   PubMed Web of Science ®Google Scholar
• NakagawaSKandaTKosugiSOhashiMSuzukiTHatakeyamaKRecurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomyJ Am Coll Surg2004198220521114759776
   PubMed Web of Science ®Google Scholar
• ReidTDDaviesILMasonJRobertsSACrosbyTDLewisWGStage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinomaClin Oncol (R Coll Radiol)201224961762422386923
   PubMed Web of Science ®Google Scholar
• SugiyamaMMoritaMYoshidaRPatterns and time of recurrence after complete resection of esophageal cancerSurg Today201242875275822370963
   PubMed Web of Science ®Google Scholar
• FletcherGHClinical dose-response curves of human malignant epithelial tumoursBr J Radiol1973465411124630323
   PubMed Web of Science ®Google Scholar
• LiJCLiuDChenMQDifferent radiation treatment in esophageal carcinoma: a clinical comparative studyJ BUON201217351251623033291
   PubMed Web of Science ®Google Scholar
• ChenYJLiuAHanCHelical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distributionMed Dosim200732316617117707195
   PubMed Web of Science ®Google Scholar
• LeclercMMaingonPHamoirMA dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approachRadiother Oncol2013106333334023541643
   PubMed Web of Science ®Google Scholar
• YuWWZhuZFFuXLSimultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma: early results of a phase II studyStrahlenther Onkol20141901197998624609941
   PubMed Web of Science ®Google Scholar
• SuhYGLeeIJKoomWSHigh-dose versus standard-dose radiotherapy with concurrent chemotherapy in stages II–III esophageal cancerJpn J Clin Oncol201444653454024771865
   PubMed Web of Science ®Google Scholar
• HeLAllenPKPotterARe-evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinomaJ Thorac Oncol2014991398140525122435
   PubMed Web of Science ®Google Scholar
• ZhangZLiaoZJinJDose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapyInt J Radiat Oncol Biol Phys200561365666415708243
   PubMed Web of Science ®Google Scholar
• KimHJSuhYGLeeYCDose-response relationship between radiation dose and loco-regional control in patients with stage II–III esophageal cancer treated with definitive chemoradiotherapyCancer Res Treat201749366967727737537
   PubMed Web of Science ®Google Scholar
• ChenCYLiCCChienCRDoes higher radiation dose lead to better outcome for non-operated localized esophageal squamous cell carcinoma patients who received concurrent chemoradiotherapy? A population based propensity-score matched analysisRadiother Oncol2016120113613927207358
   PubMed Web of Science ®Google Scholar
• WolfMCZehentmayrFSchmidtMHölzelDBelkaCTreatment strategies for oesophageal cancer – time-trends and long term outcome data from a large tertiary referral centreRadiat Oncol201276022501022
   PubMed Web of Science ®Google Scholar
• SemrauRHerzogSLVallböhmerDKocherMHölscherAHMüllerRPPrognostic factors in definitive radiochemotherapy of advanced inoperable esophageal cancerDis Esophagus201225654555422133297
   PubMed Web of Science ®Google Scholar
• SongTLiangXFangMWuSHigh-dose versus conventional-dose irradiation in cisplatin-based definitive concurrent chemoradiotherapy for esophageal cancer: a systematic review and pooled analysisExpert Rev Anticancer Ther201515101157116926235427
   PubMed Web of Science ®Google Scholar
• YuWCaiXWLiuQSafety of dose escalation by simultaneous integrated boosting radiation dose within the primary tumor guided by (18)FDG-PET/CT for esophageal cancerRadiother Oncol2015114219520025586952
   PubMed Web of Science ®Google Scholar
• ChenJGuoHZhaiTRadiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II studyOncotarget2016716227112271926992206
   PubMedGoogle Scholar
• WithersHRTaylorJMMaciejewskiBThe hazard of accelerated tumor clonogen repopulation during radiotherapyActa Oncol19882721311463390344
   PubMed Web of Science ®Google Scholar
• TrottKRCell repopulation and overall treatment timeInt J Radiat Oncol Biol Phys1990194107110752211245
   PubMed Web of Science ®Google Scholar
• JeremicBShibamotoYAcimovicLAccelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II studyInt J Radiat Oncol Biol Phys1998405106110669539560
   PubMed Web of Science ®Google Scholar
• ShiXHYaoWLiuTLate course accelerated fractionation in radiotherapy of esophageal carcinomaRadiother Oncol19995112126
   PubMed Web of Science ®Google Scholar
• ZhaoKLShiXHJiangGLWangYLate-course accelerated hyper-fractionated radiotherapy for localized esophageal carcinomaInt J Radiat Oncol Biol Phys200460112312915337547
   PubMed Web of Science ®Google Scholar
• ZhangYWChenLBaiYZhengXLong-term outcomes of late course accelerated hyper-fractionated radiotherapy for localized esophageal carcinoma in Mainland China: a meta-analysisDis Esophagus201124749550121309922
   PubMed Web of Science ®Google Scholar
• WangJHLuXJZhouJWangFA randomized controlled trial of conventional fraction and late course accelerated hyperfraction three-dimensional conformal radiotherapy for esophageal cancerCell Biochem Biophys201262110711221858589
   PubMed Web of Science ®Google Scholar
• ZhaoKLShiXHJiangGLLate course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized studyInt J Radiat Oncol Biol Phys20056241014102015990003
   PubMed Web of Science ®Google Scholar
• TongDKLawSKwongDLChanKWLamAKWongKHHistological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factorAnn Surg Oncol20101782184219220217248
   PubMed Web of Science ®Google Scholar
• ChaoYKChanSCLiuYHPretreatment T3–4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapyAnn Surg2009249339239619247024
   PubMed Web of Science ®Google Scholar
• HammoudZTKeslerKAFergusonMKSurvival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancerDis Esophagus2006192697216643172
   PubMed Web of Science ®Google Scholar
• NishimuraYSuzukiMNakamatsuKKanamoriSYagyuYShigeokaHProspective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistulaInt J Radiat Oncol Biol Phys200253113413912007951
   PubMed Web of Science ®Google Scholar
• HattMLe PogamAVisvikisDPradierOCheze Le RestCImpact of partial-volume effect correction on the predictive and prognostic value of baseline 18F-FDG PET images in esophageal cancerJ Nucl Med2012531122022213819
   PubMed Web of Science ®Google Scholar
• MuijsCTBeukemaJCPruimJA systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancerRadiother Oncol201097216517120541273
   PubMed Web of Science ®Google Scholar
• HuhJWMinJJLeeJHKimHRKimYJThe predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiationAm J Clin Oncol201235434034421422901
   PubMed Web of Science ®Google Scholar
• CapirciCRubelloDPasiniFThe role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgeryInt J Radiat Oncol Biol Phys20097451461146919419820
   PubMed Web of Science ®Google Scholar
• KatoHFukuchiMMiyazakiTPrediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomographyAnticancer Res2007274C2627263317695425
   PubMed Web of Science ®Google Scholar
• AtsumiKNakamuraKAbeKPrediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancerJ Radiat Res201354589089823520267
   PubMed Web of Science ®Google Scholar
• JaveriHXiaoLRohrenEInfluence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiationCancer2009115362463019130466
   PubMed Web of Science ®Google Scholar
• LevineEAFarmerMRClarkPPredictive value of 18-fluorodeoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancerAnn Surg2006243447247816552197
   PubMed Web of Science ®Google Scholar
• RizkNPTangLAdusumilliPSPredictive value of initial PET-SUVmax in patients with locally advanced esophageal and gastroesophageal junction adenocarcinomaJ Thorac Oncol20094787587919487968
   PubMed Web of Science ®Google Scholar
• LarsonSMErdiYAkhurstTTumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysisClin Positron Imaging19992315917114516540
   PubMedGoogle Scholar
• ChungMKJeongHSParkSGMetabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancerClin Cancer Res200915185861586819737951
   PubMed Web of Science ®Google Scholar
• RoedlJBColenRRHolalkereNSFischmanAJChoiNCBlakeMAAdenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluationRadiother Oncol200889327828618701180
   PubMed Web of Science ®Google Scholar
• JayachandranPPaiRKQuonAPostchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancerInt J Radiat Oncol Biol Phys201284247147722381904
   PubMed Web of Science ®Google Scholar
• StiekemaJVermeulenDVegtEDetecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancerClin Nucl Med2014391086286725140549
   PubMed Web of Science ®Google Scholar
• MilesKALeeTYGohVExperimental Cancer Medicine Centre Imaging Network GroupCurrent status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomographyEur Radiol20122271430144122367468
   PubMed Web of Science ®Google Scholar
• BellomiMViottiSPredaLD’AndreaGBonelloLPetraliaGPerfusion CT in solid body-tumours. Part II: clinical applications and future developmentRadiol Med20101156858874 Italian20221706
   PubMed Web of Science ®Google Scholar
• Djuric-StefanovicAMicevMStojanovic-RundicSPeskoPSaranovicDJAbsolute CT perfusion parameter values after the neoadjuvant chemoradiotherapy of the squamous cell esophageal carcinoma correlate with the histopathologic tumor regression gradeEur J Radiol201584122477248426467704
   PubMed Web of Science ®Google Scholar
• Lundsgaard HansenMFallentinELauridsenCComputed tomography (CT) perfusion as an early predictive marker for treatment response to neoadjuvant chemotherapy in gastroesophageal junction cancer and gastric cancer a prospective studyPLoS One201495e9760524845062
   PubMed Web of Science ®Google Scholar
• HayanoKOkazumiSShutoKPerfusion CT can predict the response to chemoradiation therapy and survival in esophageal squamous cell carcinoma: initial clinical resultsOncol Rep200718490190817786353
   PubMed Web of Science ®Google Scholar
• MakariYYasudaTDokiYCorrelation between tumor blood flow assessed by perfusion CT and effect of neoadjuvant therapy in advanced esophageal cancersJ Surg Oncol200796322022917450532
   PubMed Web of Science ®Google Scholar
• Djuric-StefanovicASaranovicDMicevMDoes the computed tomography perfusion imaging improve the diagnostic accuracy in the response evaluation of esophageal carcinoma to the neoadjuvant chemoradiotherapy? Preliminary studyJ BUON201419123724424659670
   PubMed Web of Science ®Google Scholar
• OnalCTorunNGulerOCYildirimBAPrognostic value of metabolic response measured by 18F-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapyNucl Med Commun201637121282128927612030
   PubMed Web of Science ®Google Scholar
• CuencaXHennequinCHindiéEEvaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomasEur J Nucl Med Mol Imaging201340447748523371374
   PubMed Web of Science ®Google Scholar
• JaveriHXiaoLRohrenEThe higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinomaCancer2009115225184519219685531
   PubMed Web of Science ®Google Scholar
• StilesBMSalzlerGJorgensenAComplete metabolic response is not uniformly predictive of complete pathologic response after induction therapy for esophageal cancerAnn Thorac Surg20139651820182523895888
   PubMed Web of Science ®Google Scholar
• YoungHBaumRCremeriusUMeasurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study GroupEur J Cancer199935131773178210673991
   PubMed Web of Science ®Google Scholar
• KimMKRyuJSKimSBValue of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapyEur J Cancer20074391385139117512192
   PubMed Web of Science ®Google Scholar
• Veit-HaibachPSchmidDStrobelKCombined PET/CT-perfusion in patients with head and neck cancersEur Radiol201323116317322772151
   PubMed Web of Science ®Google Scholar
• GohVRodriguez-JustoMEngledowAAssessment of the metabolic flow phenotype of primary colorectal cancer: correlations with microvessel density are influenced by the histological scoring methodEur Radiol20122281687169222527369
   PubMed Web of Science ®Google Scholar
• GohVEngledowARodriguez-JustoMThe flow-metabolic phenotype of primary colorectal cancer: assessment by integrated 18F-FDG PET/perfusion CT with histopathologic correlationJ Nucl Med201253568769222454485
   PubMed Web of Science ®Google Scholar
• PadhaniARMilesKAMultiparametric imaging of tumor response to therapyRadiology2010256234836420656830
   PubMed Web of Science ®Google Scholar